Share
226 Posts.
lightbulb Created with Sketch. 27
clock Created with Sketch. 22/04/24
15:20
Share
Originally posted by Silverchair:
↑
Good appointments. Dr Rodenburger helped achieve the FDA approval for Clinuvel in the past with EPP, also knows Vitiligo and obtaining FDA approval in this blockbuster should be easier as the drug is already approved with a long track record of safety and showing efficacy would appear to be quite simple relatively. Approval for a new indication easier than a whole new drug application, with safety well established, so hopefully this becomes the standard of care in just a handful of years.
Expand
Maybe management is waiting for the shorts to smash it lower and pick up more shares at a lower value? I have the same view as you. I’m not quite sure why you wouldn’t just go aggressive at the start on the back of some good news and try and get them to close some positions. Hopefully some insiders start to buy as they pump up the buy back, maybe even some other good news to throw in the mix.
(20min delay)